Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-35.16	-31.95	-23.64
Graham Fair Price	41.21	0.33	0.24
PEG	-65.35	-0.01	0.04
Price/Book	35.29	0.88	0.65
Price/Cash Flow	-85.10	-18.99	127.38
Prices/Earnings	32.36	-1.35	-2.00
Price/Sales	-83.09	8.49	50.18
Price/FCF	-85.10	-18.99	127.38
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-68.18	0.32	1.00
Operating Margin	56.96	-1.03	-2.39
ROA	-100.00	-0.04	-0.02
ROE	-0.08	-0.16	-100.00
ROIC	-0.02	-0.04	-74.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	2.31	-0.71	226.72
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.68	-2.44	-45.33
EPS QOQ	0.51	-0.99	95.25
FCF QOQ	-0.98	-10.08	-923.16
Revenue QOQ	-0.90	7.00	678.84
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	332.00	100.00
Days Sales Outstanding (DSO)	0.00	426.14	100.00
Inventory Turnover	0.00	0.27	100.00
Debt/Capitalization	0.35	0.64	83.07
Quick Ratio	0.00	0.42	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.18	0.17	-0.15
Cash	0.02	0.05	161.92
Capex	< 0.005	< 0.005	-99.70
Free Cash Flow	< 0.005	< 0.005	806.34
Revenue	< 0.005	0.02	698.81
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.00	0.63	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.49	-20.97	-121.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating